ATE44652T1 - Zubereitung mit gehalt an stabilisiertes polypeptid mit gamma-interferon aktivitaet. - Google Patents

Zubereitung mit gehalt an stabilisiertes polypeptid mit gamma-interferon aktivitaet.

Info

Publication number
ATE44652T1
ATE44652T1 AT85105092T AT85105092T ATE44652T1 AT E44652 T1 ATE44652 T1 AT E44652T1 AT 85105092 T AT85105092 T AT 85105092T AT 85105092 T AT85105092 T AT 85105092T AT E44652 T1 ATE44652 T1 AT E44652T1
Authority
AT
Austria
Prior art keywords
preparation containing
gamma interferon
interferon activity
containing stabilized
stabilized polypeptide
Prior art date
Application number
AT85105092T
Other languages
English (en)
Inventor
Yoshitake Terano
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ATE44652T1 publication Critical patent/ATE44652T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT85105092T 1984-04-26 1985-04-26 Zubereitung mit gehalt an stabilisiertes polypeptid mit gamma-interferon aktivitaet. ATE44652T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59084990A JPS60228422A (ja) 1984-04-26 1984-04-26 安定化された生理活性物質製剤
EP85105092A EP0162332B1 (de) 1984-04-26 1985-04-26 Zubereitung mit Gehalt an stabilisiertes Polypeptid mit Gamma-Interferon Aktivität

Publications (1)

Publication Number Publication Date
ATE44652T1 true ATE44652T1 (de) 1989-08-15

Family

ID=13846061

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85105092T ATE44652T1 (de) 1984-04-26 1985-04-26 Zubereitung mit gehalt an stabilisiertes polypeptid mit gamma-interferon aktivitaet.

Country Status (5)

Country Link
US (1) US4659570A (de)
EP (1) EP0162332B1 (de)
JP (1) JPS60228422A (de)
AT (1) ATE44652T1 (de)
DE (1) DE3571552D1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992271A (en) * 1982-09-23 1991-02-12 Cetus Corporation Formulation for lipophilic IL-2 proteins
US5702699A (en) * 1982-09-23 1997-12-30 Cetus Corporation Process for the recovery of lipophilic proteins
US5643566A (en) * 1982-09-23 1997-07-01 Cetus Corporation Formulation processes for lipophilic proteins
DE3687255T2 (de) * 1985-09-10 1993-05-06 Eisai Co Ltd Einen gewebe-plasminogen-aktivator enthaltende zusammensetzung.
DE3603444A1 (de) * 1986-02-05 1987-08-06 Thomae Gmbh Dr K Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha
DE3621828A1 (de) * 1986-06-28 1988-01-14 Biotest Pharma Gmbh Stabilisierung eines fuer therapeutische zwecke, insbesondere beim menschen, bestimmten interleukin-2-praeparates sowie dieses praeparat enthaltende stabilisierte waessrige loesung oder feststoff
GR871067B (en) * 1986-07-18 1987-11-19 Chugai Pharmaceutical Co Ltd Process for producing stable pharmaceutical preparation containing granulocyte colony stimulating factor
JP2629000B2 (ja) * 1986-07-18 1997-07-09 中外製薬株式会社 安定な顆粒球コロニー刺激因子含有製剤
DE3626908A1 (de) * 1986-08-08 1988-02-11 Bayer Ag Parenterale loesung
US4931544A (en) * 1986-09-04 1990-06-05 Cetus Corporation Succinylated interleukin-2 for pharmaceutical compositions
US4944941A (en) * 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
US5266310A (en) * 1987-09-17 1993-11-30 Boehringer Ingelheim International Gmbh Stabilization of therapeutically active proteins in pharmaceutical preparations
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
JP2537935B2 (ja) * 1987-12-29 1996-09-25 住友製薬株式会社 生理活性物質の農縮・脱塩方法
US5078997A (en) * 1988-07-13 1992-01-07 Cetus Corporation Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
US5221616A (en) * 1988-07-15 1993-06-22 Quidel Corporation Prevention of spontaneous complement activation in mammalian biological fluids
JP2704546B2 (ja) * 1989-04-04 1998-01-26 光利 太良 Ａｔｌｌ治療用吸入剤
DE4239877C1 (de) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung
FR2746109B1 (fr) * 1996-03-12 1998-04-17 Rhone Poulenc Rorer Sa Milieu pour la conservation de materiel biologique
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
RU2242243C2 (ru) * 2001-09-27 2004-12-20 Вертелецкий Павел Васильевич Композиции и способы потенцирования терапевтических эффектов интерферонов
US20060057106A1 (en) * 2002-12-13 2006-03-16 Chikamasa Yamashita Freeze-dried interferon-y composition for transpulmonary administration and inhalation system therefor
CN100594884C (zh) * 2008-01-07 2010-03-24 北京凯因科技股份有限公司 一种重组人干扰素注射剂
JP2010143860A (ja) * 2008-12-19 2010-07-01 Chisso Corp タンパク質の安定化剤
CN102793926A (zh) * 2011-05-20 2012-11-28 日东电工株式会社 可食性胶状组合物、胶状制剂以及胶状制剂的制造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1069329B (de) * 1959-11-19 The National Drug Company, Philadelphia, Pa. (V. St. A.) Verfahren zur Herstellung eines injizier'baren beständigen proteolytischen Enzympräparates
US4147772A (en) * 1976-02-03 1979-04-03 Merck & Co., Inc. Vaccine stabilizer
JPS5668607A (en) * 1979-11-07 1981-06-09 Teikoku Hormone Mfg Co Ltd Medical preparation with storage stability
JPS5821691A (ja) * 1981-07-29 1983-02-08 Mochida Pharmaceut Co Ltd α−及びβ−インタ−フェロンの精製方法
EP0080879B1 (de) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Stabilisiertes Interferon enthaltende pharmazeutische Zusammensetzung
ZA828580B (en) * 1981-12-23 1983-10-26 Schering Corp Interferon formulations
JPH102519A (ja) * 1996-06-12 1998-01-06 Mitsui Eng & Shipbuild Co Ltd 廃棄物熱分解ドラム及び熱分解方法

Also Published As

Publication number Publication date
US4659570A (en) 1987-04-21
EP0162332A1 (de) 1985-11-27
EP0162332B1 (de) 1989-07-19
JPS60228422A (ja) 1985-11-13
JPH0481573B2 (de) 1992-12-24
DE3571552D1 (en) 1989-08-24

Similar Documents

Publication Publication Date Title
ATE44652T1 (de) Zubereitung mit gehalt an stabilisiertes polypeptid mit gamma-interferon aktivitaet.
DE3676235D1 (de) Arzneizubereitung mit verzoegerter wirkstoffabgabe.
DE58900341D1 (de) Zweikammerspritze mit einer fuellung aus aktivitaetsempfindlichem humanen protein als wirkstoff.
IT8520242A0 (it) Polipeptide umano fisiologicamente attivo.
AU6318286A (en) Stable formulation of biologically active proteins for parenteral injection
DE3689246D1 (de) Physiologisch aktives Polypeptid BUF-3.
BG49721A3 (bg) Метод за получаване на полипептид, имащ активността на животински хормон на растежа
ATE103932T1 (de) Fusionsprotein bestehend aus gm-csf und il-3.
NO178789C (no) Fremgangsmåte for fremstilling av gamma-interferonpolypeptid med forbedret stabilitet, ekspresjonsvektor samt DNA-sekvens kodende for polypeptidene
ATE188486T1 (de) Modifizierte polypeptide mit erhoehter biologischer aktivitaet
LU90806I2 (fr) Ovidrelle-choriogonadotropine alfa et ses d-riv-s pharmaceutiquement acceptables
ES8802235A1 (es) Procedimiento para preparar un polipeptido
DK478786D0 (da) Cystein-forarmede muteiner af biologisk aktive humantumornekrosefaktorproteiner
DE68901098D1 (de) Zusammensetzung aus antikoagulantia.
DE3769707D1 (de) Therapeutisches system mit geregelter wirkstoffabgabe.
NO865191D0 (no) Gm-csf-protein, derivater derav og fremstilling og anvendelse av slike proteiner.
EP0219781A3 (de) Biologisch aktive Derivate des Human-gamma-Interferons, ihre Herstellung und Arzneimittel, die solche Derivate enthalten
DE3486111D1 (de) Menschliches gamma-interferonpolypeptidderivat.
ATE42202T1 (de) Therapeutische zubereitung mit ammoniumnitrat als wirkstoff.
DE68917061D1 (de) O-glycosylierter IGF-1.
IT1207504B (it) Composizione moderatrice dell'appetito ed antigastrica.
DE69106407D1 (de) Verfahren zur Herstellung von rekombinantem menschlichem gamma-Interferon ohne Cystein und ohne Methionin am N-Terminal.
DK2086A (da) Protraheret virkende sterilt vandigt praeparat af et peptid eller protein, dets fremstilling og anvendelse
FI861217A0 (fi) Kasvuhormonia vapauttavan tekijän sekvenssin sisältävien hybridipolypeptidien ilmentäminen E. colissa
DE3586574D1 (de) Menschliches gamma-interferon.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee